Additionally, inhibiting AKT has also been found to enhance the expansion of potent tumor-specific T cells with memory properties, indicating the potential of controlling AKT/mTOR signaling as a strategy for promoting memory T-cell development [201]. The gene discussed is MTOR; the disease is neoplasm.